Todd Brown, MD, PhD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu
  • Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
  • Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
  • Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  • Protocol Vice-Chair, ACTG 5280, ACTG 5303
  • Co-chair, ACTG 5361s
  • Co-investigator, ACTG 5257

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1108: A Phase I/II, Open-Label, Single Arm Study to...

This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...

Read More

A5273: Multicenter Study of Options for Second-Line...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More

A5207, Maintaining Options for Mothers Study (MOMS): A Phase...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More